First Page | Document Content | |
---|---|---|
Date: 2017-10-03 19:39:42 | Visterra Acquires Exclusive Patent License for Monoclonal Antibodies against Dengue Virus from MIT – Expands Company’s Therapeutic Pipeline for Infectious Diseases – Cambridge, MA – December 2, 2013 – Visterra,Add to Reading ListSource URL: www.visterrainc.comDownload Document from Source WebsiteFile Size: 74,04 KBShare Document on Facebook |